IP Library Granted Patent US 7,374,870
Granted Patent B2
US 7,374,870 · App. 11/056,347 · Granted May 20, 2008

Systems and methods for removing viral agents from blood

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,374,870
App. No.
11/056,347
Granted
May 20, 2008
Kind
B2
Abstract

Systems and methods treat plasma carrying contaminants and cellular matter that are capable of entraining contaminants. The systems and methods separate cellular matter from the plasma by filtration, thereby removing contaminants entrained within the cellular matter. The system and methods add to the plasma a photoactive material. The systems and methods emit radiation at a selected wavelength into the plasma to activate the photoactive material and thereby eradicate the contaminant that is free of entrainment by cellular matter.

Claims (11)

1. A method for treating a plasma carrying contaminants and cellular matter capable of entraining contaminants, the method comprising the steps of

conveying plasma through a first path through a filter that separates cellular matter from the plasma, thereby removing contaminants entrained within the cellular matter,

conveying the plasma from the filter through a second path that includes an attached transfer container,

mixing within the transfer container the plasma with a photoactive material to form a plasma mixture,

conveying a portion of the plasma mixture from the transfer container through a flush path that includes the second path to thereby expose contaminants in the second path to the photoactive material,

severing the second path to separate the transfer container from the filter, the transfer container, after severance from the filter, carrying a remnant of the second path, and

emitting radiation into the transfer container at a selected wavelength to activate the photoactive material in the plasma mixture and thereby eradicate the contaminant that is free of entrainment by cellular matter.

2. A method according to claim 1 wherein the flush path by passes the filter.

3. A method according to claim 1 and further including the step of venting air from the transfer container through the flush path.

4. A method according to claim 3 wherein the flush path by passes the filter.

5. A method according to claim 1 and further including the step of storing the plasma mixture in the transfer container after the radiation emitting step.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2012
From: MORGAN STANLEY & CO. LLC
To: FENWAL, INC.; FENWAL HOLDINGS, INC.
Reel/Frame 029480/0549 →
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2012
From: MORGAN STANLEY & CO. LLC
To: FENWAL, INC.; FENWAL HOLDINGS, INC.
Reel/Frame 029480/0597 →
SECOND-LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 15, 2007
From: FENWAL, INC.; FENWAL HOLDINGS, INC.
To: MORGAN STANLEY & CO. INCORPORATED
Reel/Frame 019297/0168 →
FIRST-LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 11, 2007
From: FENWAL, INC.; FENWAL HOLDINGS, INC.
To: MORGAN STANLEY & CO. INCORPORATED
Reel/Frame 019280/0211 →
PATENT ASSIGNMENT Recorded Apr 6, 2007
From: BAXTER INTERNATIONAL INC.
To: FENWAL, INC.
Reel/Frame 019129/0001 →